Global GERD Market Growth 2023-2029

Global GERD Market Growth 2023-2029

Gastroesophageal reflux disease involves the backflow of stomach’s content to mouth through esophagus which gives a burning sensation behind breast bone. Gastroesophageal reflux disease is a common digestive disorder which affects the food pipe and lower esophageal sphincter by deteriorating its elasticity. Gastroesophageal reflux disease occurs due to lifestyle changes and irregular eating habits & over consumption of fatty foods, coffee, alcoholic beverages, citrus fruits and pepper. In Gastroesophageal reflux disease there is excessive production of acid which damages the stomach lining and ultimately cause ulcers. Gastroesophageal reflux disease includes other symptoms such as regurgitation and dysphagia. However, abnormal reflux may cause uncharacteristic symptoms such as coughing, sore throat, otitis media, chest pain and enamel erosion or other dental manifestations.

LPI (LP Information)' newest research report, the “GERD Industry Forecast” looks at past sales and reviews total world GERD sales in 2022, providing a comprehensive analysis by region and market sector of projected GERD sales for 2023 through 2029. With GERD sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GERD industry.

This Insight Report provides a comprehensive analysis of the global GERD landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GERD portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global GERD market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GERD and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GERD.

The global GERD market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

The overall market has been experiencing a downturn in terms of revenue in the past several years as the leading drugs for GERD treatment have lost their patent protection, with their market shares now largely consumed by over-the-counter (OTC) and generic medications. Although loss of exclusivity of high-grossing drugs have caused a market fall-off, the demand for acid reducing drugs due to the high prevalence and incidence levels of GERD will prove beneficial to the industry from a commercial standpoint. GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives, but also extends to the healthcare system and economy.

This report presents a comprehensive overview, market shares, and growth opportunities of GERD market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Proton Pumps Inhibitors
H2 Receptor Antagonists
Antacids
Prokinetics
CAM

Segmentation by application
Hospital Pharmacy
Drug Stores
General Stores
Supermarkets

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca
Eisai
GlaxoSmithKline
Johnson & Johnson
Takeda

Key Questions Addressed in this Report

What is the 10-year outlook for the global GERD market?

What factors are driving GERD market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do GERD market opportunities vary by end market size?

How does GERD break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.